Episona is developing an epigenetic-based diagnostic platform for men’s personal health profiles. Episona’s first diagnostic panel will focus on male factor infertility (MFI) and in vitro fertilization (IVF) outcome.
Location: United States, California, Pasadena
Employees: 11-50
Total raised: $4M
Founded date: 2013
Investors 1
| Date | Name | Website |
| - | Technology... | pivotcente... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.06.2017 | Seed | $4M | - |
Mentions in press and media 6
| Date | Title | Description | Source |
| 18.10.2017 | Episona adds D2C model for male fertility test using epigene... | Despite the on-demand nature of the service, physicians will still evaluate those online requests fo... | medcitynew... |
| 06.06.2017 | Episona Raises $4m in Seed Funding | Episona Inc., a Pasadena, Calif.-based epigenetics data company, raised approx. $4m in seed funding.... | finsmes.co... |
| 01.11.2016 | Epigenetics startup Episona launches male fertility test | The second is the growing recognition that this is not a women’s health problem. Around 12 million (... | medcitynew... |
| 17.10.2016 | Sperm test 2.0: New diagnostics aim to better understand mal... | PASADENA, Calif. — Traditional sperm tests don’t reveal much. They can assess how many sperm a man ... | statnews.c... |
| - | Episona adds D2C model for male fertility test using epigene... | Fecundation – sperm cell entering in ovum One year after diagnostics startup Episona made its male ... | medcitynew... |
| - | Epigenetics startup Episona launches male fertility test | Two important trends are changing the fertility medicine landscape. The first is the overall rise i... | medcitynew... |